All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Generalization | NCIT_C54202 | [The process of formulating general concepts by abstracting common properties of instances; reasoning from detailed facts to general principles.] |
| Nicotine Dependence | NCIT_C54203 | [Physical and psychological dependence on nicotine.] |
| Drug Dependence | NCIT_C3894 | [Drug dependence - replaced the term "drug addiction" and is defined as a state, psychic and sometimes also physical, resulting from the interaction between a living organism and a drug, characterized by behavioral and other responses that always include a compulsion to take the drug on a continuous or periodic basis in order to experience its psychic effects, and sometimes to avoid the discomfort of its absence. Tolerance may or may not be present. A person may be dependent on more than one drug.] |
| SLC16A1 Gene | NCIT_C107460 | [This gene is involved in monocarboxylate transport.] |
| Lower Gingiva | NCIT_C54204 | |
| SLC16A1 wt Allele | NCIT_C107461 | [Human SLC16A1 wild-type allele is located in the vicinity of 1p12 and is approximately 45 kb in length. This allele, which encodes monocarboxylate transporter 1 protein, plays a role in the transport of monocarboxylates across the plasma membrane. Mutations in this gene are associated with erythrocyte lactate transporter defect and hyperinsulinemic hypoglycemia, familial, 7.] |
| Upper Gingiva | NCIT_C54205 | |
| Monocarboxylate Transporter 1 | NCIT_C107462 | [Monocarboxylate transporter 1 (500 aa, ~54 kDa) is encoded by the human SLC16A1 gene. This protein is involved in monocarboxylate transport across the plasma membrane.] |
| Endophytic Tumor Growth | NCIT_C54206 | |
| SLC16A4 Gene | NCIT_C107463 | [This gene plays a role in monocarboxylate transport.] |
| Malignant Small Squamous Cell | NCIT_C54207 | |
| Malignant Squamous Cell | NCIT_C36771 | |
| SLC16A4 wt Allele | NCIT_C107464 | [Human SLC16A4 wild-type allele is located in the vicinity of 1p13.3 and is approximately 28 kb in length. This allele, which encodes monocarboxylate transporter 5 protein, is involved in monocarboxylate transport across the plasma membrane.] |
| Malignant Hyperchromatic Squamous Cell | NCIT_C54208 | |
| Malignant Hyperchromatic Epithelial Cell | NCIT_C54245 | |
| Monocarboxylate Transporter 5 | NCIT_C107465 | [Monocarboxylate transporter 5 (487 aa, ~54 kDa) is encoded by the human SLC16A4 gene. This protein plays a role in the transport of monocarboxylates across the plasma membrane.] |
| Nafcillin Sodium | NCIT_C29281 | [The sodium salt form of nafcillin, a semi-synthetic naphthalene, penicillin-related Nafcillin inhibits bacterial wall synthesis by a mechanism of action similar to penicillin. Penicillinase-resistant Nafcillin is used to treat infections caused by penicillin-resistant strains of Staphylococci. (NCI04)] |
| Past Seven Days Problems with Concentration Interfering with Usual or Daily Activities | NCIT_C107411 | [A question about an individual's problems with concentration interfering with usual or daily activities over the past seven days.] |
| Grade I Lymphomatoid Granulomatosis | NCIT_C7931 | [Lymphomatoid granulomatosis characterized by the presence of a polymorphous lymphoid infiltrate without cytologic atypia. Large lymphocytes are absent or rare. By in situ hybridization, EBV-positive cells are infrequently seen.] |
| Lymphomatoid Granulomatosis | NCIT_C7930 | [An angiocentric and angiodestructive lymphoproliferative disease involving extranodal sites, comprised of Epstein-Barr virus (EBV)-positive B-cells admixed with reactive T-cells. Incidence is higher among adult males; patients with a history of immunodeficiency are at increased risk. The most common site of involvement is the lung; other common sites include brain, kidney, liver, and skin. Morphologically, three grades are recognized: grade I, II, and III. Grade III lymphomatoid granulomatosis should be approached clinically as a subtype of diffuse large B-cell lymphoma.] |